2017
DOI: 10.1152/ajpheart.00244.2017
|View full text |Cite
|
Sign up to set email alerts
|

Age- and strain-related aberrant Ca2+release is associated with sudden cardiac death in theACTCE99K mouse model of hypertrophic cardiomyopathy

Abstract: Patients with hypertrophic cardiomyopathy, particularly young adults, can die from arrhythmia, but the mechanism underlying abnormal rhythm formation remains unknown. C57Bl6 × CBA/Ca mice carrying a cardiac actin ( ACTC) E99K (Glu99Lys) mutation reproduce many aspects of human hypertrophic cardiomyopathy, including increased myofilament Ca sensitivity and sudden death in a proportion (up to 40%) of young (28-40 day old) animals. We studied the hearts of transgenic (TG; ACTC E99K) mice and their non-TG (NTG) li… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(16 citation statements)
references
References 59 publications
0
15
0
Order By: Relevance
“…HCM patients can exhibit prolonged Ca 2+ transients ( Lan et al., 2013 ), often attributed to the presence of sarcomeric protein mutations, such as E99K-ACTC1. Indeed, previous models have shown the E99K-ACTC1 mutation to increase Ca 2+ sparks and Ca 2+ transients in young transgenic mice ( Rowlands et al., 2017 ).…”
Section: Resultsmentioning
confidence: 96%
See 1 more Smart Citation
“…HCM patients can exhibit prolonged Ca 2+ transients ( Lan et al., 2013 ), often attributed to the presence of sarcomeric protein mutations, such as E99K-ACTC1. Indeed, previous models have shown the E99K-ACTC1 mutation to increase Ca 2+ sparks and Ca 2+ transients in young transgenic mice ( Rowlands et al., 2017 ).…”
Section: Resultsmentioning
confidence: 96%
“…We next investigated whether E99K-ACTC1 mutants showed any difference in arrhythmogenic event frequency, since clinical and animal studies usually show ECG abnormalities and a varying degree of enhanced arrhythmia in mutation carriers ( Arad et al., 2002 , Olson et al., 2000 , Monserrat et al., 2007 , Song et al., 2011 , Rowlands et al., 2017 ). Contraction traces obtained for EHTs clearly highlighted the presence of arrhythmogenic events ( Figure 5 A).…”
Section: Resultsmentioning
confidence: 99%
“…Our findings demonstrate that the genetic background of the mice influences the HCM phenotype caused by TnT-R92Q mutation. Moreover, it has been previously presented in two HCM mouse models that mice expressing tropomyosin (Tm-E180G) developed a more pronounced hypertrophic phenotype in FVB/N than in C57BL/6 genetic background (Prabhakar et al, 2001;Michele et al, 2002), and in mice with a mutation in actin (ACTZ E99K), the probability of sudden cardiac death was almost completely eliminated in mice bred on C57/BL6 background (Rowlands et al, 2017). The importance of the mouse genetic background on the basal cardiac function, adaptations to exercise, or stress is also well-documented (Barnabei et al, 2010;Peng et al, 2011;Gibb et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…PLNKO mice used in this project were in FVB/N genetic background (Gaffin et al, 2011). Since it is well-documented that genetic background may have a significant effect on the HCM phenotype (Prabhakar et al, 2001;Michele et al, 2002;Rowlands et al, 2017), we first rederived and characterized TnT-R92Q mice in FVB/N background. We crossed TnT-R92Q heterozygous male with FVB/N female and created F1 generation of mice.…”
Section: Generation Of New Transgenic Micementioning
confidence: 99%
“…Finally, the majority of myopathy-causing mutations are heterozygous, indicating one normal and one mutant allele; the extent to which the abnormality is manifested is rather variable and a significant proportion of patients carrying the mutation never show the symptoms of myopathy [ 14 ]. This variable penetrance is itself largely due to a variable genetic background with some patients having compensatory genetic or epigenetic characteristics, as has been shown in mouse models [ 15 , 16 ].…”
Section: From Clinic To Fundamental Studiesmentioning
confidence: 99%